Literature DB >> 1536891

Syndromes of androgen resistance.

J D Wilson1.   

Abstract

Androgen resistance can be divided into two broad categories: deficiency in 5 alpha-reductase and defects in the androgen receptor. Studies of these two disorders have provided insight into both the normal pathway of androgen action and into the pathogenesis of abnormal sexual development. 5 alpha-Reductase deficiency is a rare autosomal recessive disorder involving the 5 alpha-reductase 2 enzyme; affected males exhibit a defect in virilization most evident as impairment of the virilization of the external genitalia and urogenital sinus. Disorders of the androgen receptor in genetic males cause a spectrum of developmental abnormalities that vary from phenotypic females to men with mild defects in virilization. On functional grounds we have divided these defects into absence of receptor function, qualitatively abnormal receptors, quantitative defects in receptor amount, and apparently normal receptor. Cloning of the cDNA for the receptor and application of the polymerase chain reaction techniques for sequencing of mutants made it possible to analyze these defects at the molecular level. It is now apparent that the functional categorization underestimated the complexity of the mutations. Indeed, major gene deletions and/or rearrangements, single amino acid substitutions, and premature termination codons all can cause variably severe functional abnormalities.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1536891     DOI: 10.1095/biolreprod46.2.168

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  15 in total

Review 1.  Racial differences in the androgen/androgen receptor pathway in prostate cancer.

Authors:  C A Pettaway
Journal:  J Natl Med Assoc       Date:  1999-12       Impact factor: 1.798

2.  Genetic interactions of the androgen and Wnt/beta-catenin pathways for the masculinization of external genitalia.

Authors:  Shinichi Miyagawa; Yoshihiko Satoh; Ryuma Haraguchi; Kentaro Suzuki; Taisen Iguchi; Makoto M Taketo; Naomi Nakagata; Takahiro Matsumoto; Ken-ichi Takeyama; Shigeaki Kato; Gen Yamada
Journal:  Mol Endocrinol       Date:  2009-03-12

3.  Codon repeats in genes associated with human diseases: fewer repeats in the genes of nonhuman primates and nucleotide substitutions concentrated at the sites of reiteration.

Authors:  P Djian; J M Hancock; H S Chana
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

Review 4.  Genes involved in testicular development and function.

Authors:  D J Lamb
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 5.  Endocrine findings in male pseudohermaphroditism.

Authors:  M Zachmann
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

6.  Androgen receptor gene mutations in human prostate cancer.

Authors:  J R Newmark; D O Hardy; D C Tonb; B S Carter; J I Epstein; W B Isaacs; T R Brown; E R Barrack
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

7.  A and B forms of the androgen receptor are present in human genital skin fibroblasts.

Authors:  C M Wilson; M J McPhaul
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

8.  Human androgen receptor expressed in HeLa cells activates transcription in vitro.

Authors:  P De Vos; J Schmitt; G Verhoeven; H G Stunnenberg
Journal:  Nucleic Acids Res       Date:  1994-04-11       Impact factor: 16.971

9.  Testicular dysgenesis does not affect expression of anti-müllerian hormone by Sertoli cells in premeiotic seminiferous tubules.

Authors:  R Rey; L al-Attar; F Louis; F Jaubert; P Barbet; C Nihoul-Fékété; J L Chaussain; N Josso
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

10.  Pituitary apoplexy developed in a patient with androgen insensitivity syndrome.

Authors:  H Watanobe; H Kawabe
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.